Individuals with biallelic BRCA2 pathogenic variants usually suffer from a severe form of FA characterized by BMF, multiple congenital defects, and severe cancer predisposition as patients develop leukemia and/or multiple solid tumors (mainly Wilms and brain tumors) in the first decade of life. This evidence concerns the gene BRCA2 and cancer.